• Issue

    The Prostate: Volume 82, Issue 1

    1-166
    January 1, 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 1
  • First Published: 09 December 2021

ORIGINAL ARTICLES

Free to Read

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer

Takafumi Yanagisawa MD, PhD,  Takahiro Kimura MD, PhD,  Keiichiro Mori MD,  Hirotaka Suzuki MD,  Takayuki Sano MD,  Takashi Otsuka MD,  Yuya Iwamoto MD,  Wataru Fukuokaya MD,  Keiichiro Miyajima MD,  Yuki Enei MD,  Keigo Sakanaka MD,  Akihiro Matsukawa MD,  Hajime Onuma MD,  Koki Obayashi MD,  Shunsuke Tsuzuki MD, PhD,  Kenichi Hata MD, PhD,  Tatsuya Shimomura MD, PhD,  Jun Miki MD, PhD,  Shin Egawa MD, PhD, 
  • Pages: 3-12
  • First Published: 24 September 2021
Free to Read

Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms

Jeremy Yuen-Chun Teoh MBBS,  Xiao-Yu Tian PhD,  Christine Yim-Ping Wong MPhil,  Chi-Wai Lau BSc,  Chak-Kwong Cheng PhD,  Victor Wai-Lun Tang MBChB,  Ronald Cheong-Kin Chan MBBS,  Yu Huang PhD,  Chi-Fai Ng MBChB, MD, 
  • Pages: 13-25
  • First Published: 27 September 2021
Free to Read

Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer

Yingying Yin,  Qianmei Liu,  Yingying Shao,  Xinyuan He,  Qingyi Zhu PhD,  Shan Lu PhD,  Ping Liu PhD, 
  • Pages: 26-40
  • First Published: 30 September 2021
Free to Read

Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy

Masaya Jimbo MD, PhD,  Jack R. Andrews MD,  Mohamed E. Ahmed MBBCh,  Ayca Dundar MD,  R. Jeffrey Karnes MD,  Alan H. Bryce MD,  Ayse T. Kendi MD,  Eugene D. Kwon MD,  Val J. Lowe MD,  Michael S. Bold MD, 
  • Pages: 41-48
  • First Published: 11 October 2021
Free to Read

Restoration of erectile function by a combination of antiapoptosis by JNK inhibitor and preservation of smooth muscle or endothelium by hepatocyte growth factor in a rat model of cavernous nerve injury

Soo Woong Kim MD, PhD,  Junghoon Lee MD,  Sohee Oh PhD,  Hwancheol Son MD, PhD,  Min Chul Cho MD, PhD, 
  • Pages: 49-58
  • First Published: 05 October 2021
Open Access

Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983

Ru Huang,  Yuhan Liu,  Bingsheng Li MD,  Ruixiao Wang,  Alexander Tamalunas MD,  Raphaela Waidelich MD,  Frank Strittmatter MD,  Christian G. Stief MD,  Martin Hennenberg PhD, 
  • Pages: 59-77
  • First Published: 11 October 2021
Open Access

Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients

Mike Wenzel MD, BSc,  Claudia Collà Ruvolo MD,  Christoph Würnschimmel MD,  Luigi Nocera MD,  Zhe Tian MSc,  Fred Saad MD PhD,  Alberto Briganti MD PhD,  Derya Tilki MD, PhD,  Markus Graefen MD, PhD,  Andreas Becker MD, PhD,  Frederik Roos MD, PhD,  Philipp Mandel MD, PhD,  Felix K. H. Chun MD, PhD,  Pierre I. Karakiewicz MD, PhD, 
  • Pages: 78-85
  • First Published: 11 October 2021
Open Access

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy

Liam Widjaja,  Thorsten Derlin MD,  Tobias L. Ross PhD,  Frank M. Bengel MD,  Rudolf A. Werner MD, 
  • Pages: 86-96
  • First Published: 11 October 2021
Free to Read

AT-rich interaction domain 5A regulates the transcription of interleukin-6 gene in prostate cancer cells

Wataru Ikeuchi MS,  Yuriko Wakita PhD,  Guoxiang Zhang PhD,  Chun Li MD, MS,  Keiichi Itakura PhD,  Takahiro Yamakawa PhD, 
  • Pages: 97-106
  • First Published: 11 October 2021
Free to Read

Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis

Zhuqing Shi PhD,  Lucy Lu MD,  William Kyle Resurreccion BS,  Wancai Yang MD,  Jun Wei PhD, MSE,  Qiang Wang PhD,  Valentina Engelmann AS-CLS,  Siqun Lilly Zheng MD,  Kathleen A. Cooney MD, MACP,  William B. Isaacs PhD,  Brian T. Helfand MD, PhD,  Jim Lu MD, PhD,  Jianfeng Xu MD, DrPH, 
  • Pages: 107-119
  • First Published: 21 October 2021
Open Access

Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients

Benedikt Hoeh MD,  Christoph Würnschimmel MD,  Rocco S. Flammia MD,  Benedikt Horlemann MD,  Gabriele Sorce MD,  Francesco Chierigo MD,  Zhe Tian MSc,  Fred Saad MD,  Markus Graefen MD,  Michele Gallucci MD,  Alberto Briganti MD,  Carlo Terrone MD,  Shahrokh F. Shariat MD,  Luis A. Kluth MD,  Philipp Mandel MD,  Felix K. H. Chun MD,  Pierre I. Karakiewicz MD, 
  • Pages: 120-131
  • First Published: 18 October 2021
Free to Read

Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue

Wei Yuan PhD,  Baoqin Liu PhD,  Miloslav Sanda PhD,  Renhuizi Wei Msc,  Julius Benicky PhD,  Zora Novakova PhD,  Cyril Barinka PhD,  Radoslav Goldman PhD, 
  • Pages: 132-144
  • First Published: 18 October 2021
Free to Read

Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations

Ceren Şeref PhD,  Ömer Acar MD,  Mert Kılıç MD,  Metin Vural MD,  Yeşim Sağlıcan MD,  Hilal Saraç PhD,  Bilgen Coşkun MD,  Ümit İnce MD,  Tarık Esen MD,  Nathan A. Lack PhD, 
  • Pages: 145-153
  • First Published: 21 October 2021
Open Access

Aqueous metabolome of tissue-specific conditional Pten-knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma

Sangyub Kim PhD,  Li Li PhD,  Jinhui Zhang PhD,  Cheng Jiang MD,  Junxuan Lü PhD, 
  • Pages: 154-166
  • First Published: 18 October 2021